ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011